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Abstract
Studies have suggested links between colonic fermentation of dietary fibers and improved
metabolic health. The objectives of this study were to determine if non-digestible feruloy-
lated oligo- and polysaccharides (FOPS), a maize-derived dietary fiber, could counteract
the deleterious effects of high-fat (HF) feeding in mice and explore if metabolic benefits
were linked to the gut microbiota. C57BL/6J mice (n = 8/group) were fed a low-fat (LF; 10
kcal% fat), HF (62 kcal% fat), or HF diet supplemented with FOPS (5%, w/w). Pronounced
differences in FOPS responsiveness were observed: four mice experienced cecal enlarge-
ment and enhanced short chain fatty acid production, indicating increased cecal fermenta-
tion (F-FOPS). Only these mice displayed improvements in glucose metabolism compared
with HF-fed mice. Blooms in the gut microbial genera Blautia and Akkermansia were
observed in three of the F-FOPSmice; these shifts were associated with reductions in body
and adipose tissue weights compared with the HF-fed control mice. No improvements in
metabolic markers or weights were detected in the four mice whose gut microbiota did not
respond to FOPS. These findings demonstrate that FOPS-induced improvements in weight
gain and metabolic health in mice depended on the ability of an individual’s microbiota to
ferment FOPS.
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Introduction
Obesity is associated with a cluster of metabolic disorders including insulin resistance, type 2
diabetes, and cardiovascular disease [1]. These diseases diminish the quality of life for a grow-
ing proportion of the world’s population, and there is an urgent need to develop strategies that
reduce the prevalence of these diseases. Research during the last decade has clearly demon-
strated that the microbial community colonizing the gastrointestinal tract (the gut microbiota)
contributes to the pathologies associated with obesity [2–6]. The gut microbiota therefore con-
stitutes a promising therapeutic target for dietary strategies to prevent or treat these diseases
[7]. Dietary fiber consumption is one strategy by which the gut microbiota composition can be
modulated towards putatively beneficial microbial ecologies. In addition, the fermentation of
dietary fiber leads to the synthesis of short chain fatty acids (SCFA), which contribute to the
exclusion of detrimental bacteria, inhibit the metabolism of harmful substances, strengthen gut
barrier function, and exert beneficial effects on the production of gut hormones. By doing so,
SCFA may benefit the host by improving glucose homeostasis and blood lipid profiles as well
as reducing body weight and colon cancer risk [8]. Together, these combined effects would
likely contribute to long-term prevention of the chronic subclinical inflammation that can
develop into metabolic syndrome [9–12].
In a previous study, we identified a hydrothermal process to produce non-digestible feruloy-
lated oligo- and polysaccharides (FOPS) from maize [13]. FOPS are composed of hydrolysates
of the hemicellulosic component of maize bran, which is principally a complex heteroxylan
comprised of a (1, 4)-linked β-D-xylopyranosyl backbone with single or multi-unit branches
consisting of α-L-arabinofuranose, β-D-xylopyranose, β-D-glucuronic acid, and a non-carbo-
hydrate antioxidant, ferulic acid [14]. The multi-unit branches in maize heteroxylan are rare
among cereal dietary fibers, as are some of the linkages between sugars on these branches [e.g.,
(1, 2)- and (1, 3)-linkages between β-D-xylopyranose and α-L-arabinofuranose]. Our previous
findings with human fecal in vitro fermentations demonstrated that this complex structure is
more difficult for the microbiota to ferment compared to the hemicellulosic components of
other cereals and thus may contribute to sustained SCFA production [13, 15]. Dietary fibers
capable of supporting prolonged saccharolytic bacterial fermentation may help in maintaining
beneficial SCFA production in the distal colon, which is low in SCFA and particularly prone to
disease [16–18]. Our in vitro studies have also shown enhanced SCFA production of FOPS
from maize bran, especially butyrate, compared with fructans and FOPS produced from wheat
bran. Additionally, because of their high ferulic acid content, fermented FOPS samples pos-
sessed high levels of antioxidant activity, which may be beneficial for reducing the damaging
effects of free radicals, including nitric oxide, released in the colon during inflammatory
responses [19, 20]. Because of these promising in vitro results, the objective of this present
study was to determine the impact of FOPS consumption in counteracting the deleterious
effects of high-fat (HF) feeding in mice and explore if metabolic benefits were linked to FOPS
modulating the gut microbiota.
Materials and Methods
Production and Composition of FOPS
FOPS from maize bran was produced as previously described [13]. In brief, 150 g of finely
milled maize bran (Bunge Milling, Crete, NE) was dispersed in 1.35 L of water in a 2 L high-
pressure reactor (Model 4848, Parr, Moline, IL). The slurry was heated to 190°C at the rate of
4°C/min under constant stirring (400 rpm) and then cooled to 80°C using an internal serpen-
tine coil with circulating cold water (ca. 15 min). The slurry was centrifuged at 10,000 × g for
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10 min and the supernatant retained. Supernatants from a total of ~25 batches were pooled
and loaded into a reverse osmosis system (Model R, GEA Filtration, Hudson, WI, USA)
equipped with a membrane (molecular weight cut off: 1000; GE 1207106, GEA Process Engi-
neering Inc., Hudson, WI, USA). The FOPS were circulated with ~75 L of distilled water to sep-
arate contaminants (permeate) from FOPS (retentate). Following reverse osmosis, FOPS were
freeze-dried (Thermal-Vac Technology Inc., Orange, CA, USA). The freeze-dried material was
subsequently analyzed for total carbohydrate, total starch, free monosaccharides, free and
esterified ferulic acid, furfural, hydroxymethylfurfural (HMF), and protein as described [13].
FOPS were calculated as the sum of all non-starch polymeric sugars and esterified ferulate [13].
The final FOPS preparation contained 59% FOPS, 16% starch, 3.4% other sugars, 2.9% protein,
and 8.8% moisture (S1 Table).
Experimental Diets and Mouse Experiment
The three diets used in the study were prepared by a commercial provider (Research Diets,
New Brunswick, NJ USA): low fat [LF; rodent diet with 10 kcal% fat; D12450K], HF (rodent
diet with 62% kcal% fat; D12492), and HF supplemented with 5% FOPS (w/w; S2 Table). FOPS
were incorporated into the HF diet at the expense of cellulose. Because the FOPS preparation
contained small quantities of starch and protein, the amounts of these compounds in the HF
diet formulation were reduced to the extent necessary to match the macronutrient and energy
content of the HF control diet. The LF diet was included to confirm metabolic aberrations
induced by the HF diet.
Twenty-four eight-week old male C57BL/6J mice were purchased from The Jackson Labora-
tory (Bar Harbor, Maine, USA). Animals were maintained in an environment with a 14 h light/
10h dark cycle and controlled temperature and humidity. Mice were randomly assigned to one
of the three dietary treatments (n = 8 mice/group), housed as pairs in individually ventilated
cages, maintained on autoclaved bedding, and fed autoclaved water. While acclimating to their
environment for one week, all mice were fed a regular autoclaved chow diet (Purina Lab Diets,
St. Louis, MO) before starting the dietary interventions, which were provided for eight weeks.
Diet replacement and recording of both food intake and body weights were performed weekly.
Feces were collected from individual mice three times during the experiment (weeks 0, 1,
and 8) and stored at -80°C until further analysis. After eight weeks of experimental diet feeding,
mice were euthanized via CO2 asphyxiation. Blood was harvested by cardiac puncture and
plasma was collected by centrifugation at 13,000 × g for 3 min at 4°C. Adipose tissues, full ceca,
and empty cecal tissues were weighed at the time of collection. All biological samples were
snap frozen in liquid nitrogen and then stored at -80°C until analysis. The Institutional Animal
Care and Use Committee at the University of Nebraska-Lincoln approved all procedures
involving animals (Project ID 817: Microbial Perturbation of Gastrointestinal Homeostasis).
Intraperitoneal Glucose Tolerance Test
An intraperitoneal glucose tolerance test (ipGTT) was performed after seven weeks of dietary
intervention. Mice were fasted in clean cages for 6 h prior to the test. Thirty minutes prior to
the test, blood was collected from the tip of the tail to measure fasting glucose concentration
using a glucose meter (ACCU-CHEK, Aviva Plus system, Indianapolis, IN, USA). An aliquot
of blood was also saved for subsequent insulin analysis via ELISA (Mercodia Insulin ELISA
Kit, Uppsala Sweden). At time zero, a glucose solution (20 g/100 mL) was injected into the peri-
toneal cavity (1 g glucose/kg body weight) [21]. Blood glucose was then measured at 0, 15, 30,
60, 90 and 120 min after glucose injection. An index of insulin resistance was calculated using
the formula: [fasting glucose (mg/dL)  fasting insulin (μU/mL)]/405 [22].
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Plasma Lipids and Hormones
Plasma amylin, C-peptide, leptin, and resistin were measured by a multiplex immunoassay
(Mouse Metabolic Magnetic Bead Panel Kit; Merck Millipore, Billerica, MA, USA) using a
MAGPIX instrument (Luminex Corporation, Austin, TX). Plasma triacylglycerol and total
cholesterol were determined using an enzymatic reaction and spectrophotometric detection
(Infinity TG/Cholesterol kit; Thermo Electron, Waltham, MA, USA).
Cecal Short and Branch Chain Fatty Acids
SCFA (acetate, propionate, and butyrate) and branched chain fatty acids (BCFA) (iso-butyrate
and iso-valerate) were quantified by gas chromatography in the cecal contents collected at nec-
ropsy [23]. Quantification was done by means of internal calibration with 2-ethyl-butyric acid.
Characterization of the Fecal Microbiota Composition
DNA was extracted from mouse fecal samples after mechanical and enzymatic bacterial cell
lysis as previously described [24]. Microbial composition was assessed at weeks 0, 1, and 8 by
16S rRNA gene tag sequencing (MiSeq; Illumina; San Diego, CA, USA) [25] targeting the
V5-V6 region with primer pair 784F (5’-RGGATTAGATACCC-3’) and 1064R (5’-CGACR
RCCATGCANCACCT-3’). Initial quality filtering and demultiplexing of the resulting reads
was performed with Illumina Software. Next, reads were merged with the merge-Illumina-
pairs application, which also removed primers and performed further quality check of the
sequences [26]. Subsequently, the UPARSE pipeline [27] was used to process the sequences
and perform operational taxonomic unit (OTU) clustering, using a 98% similarity cutoff.
Sequences were independently subjected to taxonomic classification for phylum to genus char-
acterization of the fecal microbiome using the RDPMultiClassifier 1.1 from the Ribosomal
Database Project [28]. Taxonomic bins were computed as proportions based on the total num-
ber of sequences in each sample. α-Diversity was calculated using QIIME [29].
Statistical Analysis
Results are presented as mean ± SEM except where otherwise indicated. The impact of dietary
treatments on body mass, metabolic markers, and gut microbiota α-diversity were analyzed
using one-factor ANOVA (diet). Body weight and blood glucose during the ipGTT were ana-
lyzed using two-factor repeated measures ANOVA (diet, time). Significant differences for
ANOVA models were assessed using Bonferroni’s post hoc test. Correlations between bacterial
groups and host physiological measurements in the HF- and FOPS-fed mice were calculated
using Pearson's coefficients. Microbial taxa that were present at<1% abundance in all mice at
all time points were excluded from the analyses. P< 0.05 was used to consider a difference as
statistically significant. All data were analyzed using SAS software (version 9.4; SAS Institute,
Cary, NC, USA) with the exception of PCA, which was performed using XLSTAT software
(Statistical Innovations, Belmont, MA USA).
Results
Mice Fed a High-Fat Diet Supplemented with FOPS Experienced Inter-
Individual Variation in Fermentation
Previous work from our laboratory showed sustained in vitro fermentation of non-digestible
feruloylated oligo- and polysaccharides (FOPS) from maize by the human fecal microbiota
[13]. We observed dramatic cecal enlargement in four mice fed a HF diet supplemented with
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FOPS, indicative of bacterial fermentation (Fig 1). The other four FOPS fed mice and all of the
mice in the other treatment groups contained ceca of normal size. This variation was not due
to a cage effect, as two mice with enlarged ceca were from the same cage, while the other two
shared cages with mice that had ceca of normal size. The total SCFA pool was significantly ele-
vated in the mice with enlarged ceca compared to all other animals (Fig 2A). These mice also
showed marked increases in acetate and propionate pools (Fig 2B and 2C). Butyrate produc-
tion was elevated in this group as well, but with wide variation among mice (Fig 2D). A signifi-
cant increase in BCFA production was detected in the mice with enlarged ceca compared with
others (Fig 2E); however, the BCFA/SCFA ratio was significantly lower for the mice with
enlarged ceca compared to those in other groups (Fig 2F), suggesting that the elevated BCFA
production was a result of greater overall fermentative activity and not a tendency toward
putrefactive fermentation. No significant differences in cecal SCFA or BCFA pools were evi-
dent among LF, HF, and N-FOPS mice (Fig 2). Given that increased cecal weight and elevated
SCFA pool were strong indications of increased fermentation and metabolic activity of the gut
microbiota [30], we divided the mice on the FOPS diet into those with enlarged ceca that fer-
mented the FOPS (F-FOPS; n = 4) and those with ceca of normal size (N-FOPS; n = 4) for sub-
sequent data analysis and presentation.
Fermentation of FOPSWas Associated with Limited Weight Gain and
White Fat Deposition
No significant differences in feed intake were observed between HF- and FOPS-fed mice (S1
Fig). However, compared to HF-fed controls, F-FOPS mice experienced a significantly slower
rate of weight gain during the eight-week feeding study (Fig 3A) and ultimately gained less
weight (Fig 3B). F-FOPS mice also experienced a significant reduction in epididymal, subcuta-
neous, and visceral adipose tissue weights compared with the HF-fed control mice (Fig 3C–
3E). Remarkably, three mice (6, 7, and 8) within the F-FOPS group were found to consistently
have adipose tissue weights similar to those of LF-fed mice, while one F-FOPS mouse (3) had
adipose tissue weights consistently similar to those of N-FOPS and HF-fed mice. In contrast to
F-FOPS mice, body weight gain and adipose tissue weights of the N-FOPS mice mirrored those
of the HF-fed control mice. HF feeding also significantly elevated plasma cholesterol and tria-
cylglycerol levels compared to LF-fed mice, but FOPS feeding did not improve the concentra-
tions of these lipids (S2 Fig). No differences in stool consistency were observed among all mice
on study (data not shown).
Mice that Were Capable of Fermenting FOPS Experienced Decreases in
Fasting Plasma Glucose and Insulin Levels
As expected, HF feeding increased fasting bood glucose and insulin levels, as well as elevated
the index of insulin resistance and impaired glucose tolerance compared with LF feeding (Fig
4), indicating that metabolic aberrations related to impaired glucose tolerance existed in HF-
fed control mice. F-FOPS mice experienced significant improvements in both fasting glucose
and insulin levels, which were accompanied by a 79% reduction in the index of insulin resis-
tance compared with HF-fed mice. In contrast to weight gain and adipose tissue weight obser-
vations, mouse 3 clustered with the other F-FOPS mice, showing similar glycemic and
insulinemic profiles to mice 6, 7, and 8. No significant improvements in metabolic parameters
were observed for N-FOPS mice compared to HF-fed controls.
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Plasma Peptide Hormone Levels Were Improved in Mice that
Fermented FOPS
As expected, HF feeding increased plasma C-peptide and amylin concentrations compared to
LF-fed mice (Fig 5A and 5B). Consistent with our observations for insulin levels and the
ipGTT, F-FOPS mice experienced a significant reduction in plasma C-peptide concentrations
compared to both HF-fed controls and N-FOPS mice (Fig 5A). Plasma levels of the peptide
hormone amylin (secreted from pancreatic β-cells) were significantly improved in F-FOPS
mice compared to N-FOPS mice (Fig 4B).
The peptide hormones resistin and leptin, which originate from adipose tissue, were also
elevated in HF-fed control mice, but were significantly reduced in F-FOPS mice (Fig 5C and
5D). Moreover, leptin levels were also significantly decreased in F-FOPS mice compared with
N-FOPS mice. Mouse 3 in the F-FOPS group showed separation from mice 6, 7, and 8 for lep-
tin but not for resistin.
FOPS Feeding Resulted in Divergent Fecal Microbiota Compositions
To explore if the metabolic benefits induced by FOPS supplementation, and especially the
inter-individual variability in these effects, were associated with shifts in the gut microbiota, we
characterized the fecal microbiota by 16S rRNA tag Illumina sequencing. α-Diversity of the
fecal microbiota significantly decreased in HF- and FOPS-fed mice at week 1 compared with
the LF group (Fig 6A). At week 8, the α-diversity of the mice in the F-FOPS group further
decreased compared with the HF and N-FOPS groups. Principal component analysis (PCA)
based on OTU abundance showed no clustering by treatment group at baseline (Fig 6B),
Fig 1. Inter-individual variation in full cecal weights of mice fed a HF diet supplemented with FOPS.Data are presented as mean ± SEM; n = 8 mice/
group for LF, HF, and FOPS; n = 4 mice/group for N-FOPS and F-FOPS; mouse numbers are shown for FOPSmice to track individual mice across figures; *
indicates a significant difference (p < 0.05) between the indicated treatments using Bonferroni’s multiple comparison test with the following comparisons: LF
vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; N-FOPS vs. F-FOPS.
doi:10.1371/journal.pone.0146144.g001
Feeding Maize-Derived Oligo- and Oligosaccharides
PLOS ONE | DOI:10.1371/journal.pone.0146144 January 5, 2016 6 / 17
Fig 2. Cecal SCFA in mice after 8 weeks of feeding. SCFA (A), acetate (B), propionate (C), butyrate (D), BCFA (E), SCFA/SCFA ratio (F); data are
presented as mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS; mouse numbers are shown for FOPSmice to track
individual mice across figures; * indicates a significant difference (p < 0.05) between the indicated treatments using Bonferroni’s multiple comparison test
with the following comparisons: LF vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; F-FOPS vs. Y-FOPS.
doi:10.1371/journal.pone.0146144.g002
Fig 3. Body and adipose tissue weights in mice after 8 weeks of feeding. Body weight (A), body weight gain (B), and visceral (C), epididymal (D), and
subcutaneous (E) adipose tissue weights; data are presented as mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS;
mouse numbers are shown for FOPSmice to track individual mice across figures; * indicates a significant difference between the indicated treatments using
Bonferroni’s multiple comparison test with the following comparisons: LF vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; N-FOPS vs. F-FOPS; #, p<0.05 vs. HF; †,
p<0.05 vs. HF; ‡, p<0.05 vs. N-FOPS.
doi:10.1371/journal.pone.0146144.g003
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whereas principal component 1 separated FOPS-fed mice from HF- and LF-fed mice at week 1
(Fig 6C)—a separation that persisted after 8 weeks of feeding (Fig 6D). F-FOPS mice 6, 7, and 8
clustered separately from the other mice, while F-FOPS mouse 3 was more similar to the
N-FOPS mice.
At week 0, all mice had similar baseline microbial compositions (Fig 7) that were dominated
by members of the Firmicutes and Bacteroidetes phyla (S3 Table). Because of the disparate
responses to FOPS among the FOPS fed mice, we were particularly interested in assessing dif-
ferences between N-FOPS and F-FOPS mice at this time point. At the phylum level, N-FOPS
and F-FOPS mice had significantly higher proportions of Proteobacteria (S3 Table). At the
OTU level, N-FOPS mice harbored significantly more of one OTU belonging to the Lachnos-
piraceae family (OTU 64) compared with the F-FOPS mice, and the F-FOPS mice had signifi-
cantly higher Acetivibrio (OTU 259) levels compared to N-FOPS mice (S4 Table).
Many changes could already be noted by week 1, indicating the rapid effect of diet on alter-
ing the microbiota composition (Fig 7). The F-FOPS and N-FOPS mice also became distin-
guishable from one another, with a number of significant differences at the phylum (S3 Table)
and OTU (S5 Table) levels. In particular, 19 OTUs belonging to the Lachnospiraceae (OTUs 7,
Fig 4. Intraperitoneal glucose tolerance test in mice after 7 weeks of feeding. Fasting glycemia (A), fasting insulinemia (B), index of insulin resistance
(C), and glucose tolerance curve (D); data are presented as mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS; mouse
numbers are shown for FOPSmice to track individual mice across figures; * indicates a significant difference (p < 0.05) between the indicated treatments
using Bonferroni’s multiple comparison test with the following comparisons: LF vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; F-FOPS vs. Y-FOPS; #, p<0.05 vs.
HF.
doi:10.1371/journal.pone.0146144.g004
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32, 39, 42, 43, 66, 69, 99, 111, 185, 186, 209, 699, and 712), Ruminococcaceae (OTU 104, and
167), and Erysipelotrichaceae (OTU 159) families and Dorea (OTU 75) andMarvinbryantia
(OTU 155) genera were significantly higher in N-FOPS mice, while 3 OTUs belonging to the
Ruminococcaceae family (OTU 225) and Bifidobacterium (OTU 22) and Acetivibrio (OTU 27)
genera were significantly higher in F-FOPS mice.
The most remarkable change in microbiota composition over the course of the study was
the substantial increase in OTUs belonging to the Blautia and Akkermansia genera that
occurred in three of the F-FOPS mice at week 8 (Fig 7). Combined, these two OTUs repre-
sented approximately 80% of the fecal microbiota in F-FOPS mice 6, 7, and 8 and explain the
substantial decrease in α-diversity in these mice. Notably, these are the same three mice that
clustered together on the PCA plots (Fig 6B–6D). In contrast, mouse 3 (also in the F-FOPS
group as it had an enlarged cecum), did not harbor elevated Blautia and Akkermansia at the
end of the study.
Fig 5. Plasma C-peptide and selected hormone concentrations in mice after 8 weeks of feeding. C-peptide (A), amylin (B), resistin (C), and leptin (D);
data are presented as mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS; mouse numbers are shown for FOPSmice
to track individual mice across figures; * indicates a significant difference (p < 0.05) between the indicated treatments using Bonferroni’s multiple comparison
test with the following comparisons: LF vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; N-FOPS vs. F-FOPS.
doi:10.1371/journal.pone.0146144.g005
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At week 8, F-FOPS mice had significantly elevated Verrucomicrobia compared with the HF
and N-FOPS groups (S3 Table). This was accompanied by a significant decrease in Firmicutes
compared with the HF-fed mice. In contrast, the N-FOPS mice had significantly elevated Bac-
teroidetes compared with the HF mice. Both N-FOPS and F-FOPS had significantly lower pro-
portions of many OTUs belonging to the Peptococcaceae (OTU 8), Lachnospiraceae (OTU 19,
25, 46, 53, 76, 93, 96, 179), and Ruminococcaceae (OTU 129, 638) families, Oscillibacter (OTU
11), Anaerotruncus (OTU 51, 141), Coprobacillus (OTU 84), Coprococcus (OTU 127), Dorea
(OTU 153, 169) genera, and Lactococcus lactis (OTU 2, 695) species compared with the HF-fed
mice, but had higher abundances of one OTU belonging to the Porphyromonadaceae (OTU
10) family and one OTU belonging to the Anaerotruncus (OTU 62) genus (S6 Table). Only 4
OTUs were significantly elevated in the F-FOPS mice compared with both the HF-fed mice
and the N-FOPS mice. These corresponded to OTUs belonging to the Ruminococcaceae (OTU
89) family and the Akkermansia (OTU 1), Blautia (OTU 9), and Anaerotruncus (OTU 190)
genera.
Fig 6. Diversity and principal components analysis of fecal bacterial communities in mice at 0, 1, and 8 weeks of feeding. α-Diversity (A) and
principal components analysis of OTU abundances (B-D); data are presented in (A) as the mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for
N-FOPS and F-FOPS. (B-D) blue dots represent LF, green dots represent HF, red dots represent N-FOPS, purple dots represent F-FOPS; mouse numbers
are shown for FOPSmice to track individual mice across figures; *indicates a significant difference (p < 0.05) between the indicated treatments using
Bonferroni’s multiple comparison test with the following comparisons: LF vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; N-FOPS vs. F-FOPS.
doi:10.1371/journal.pone.0146144.g006
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Microbial Composition and Fermentation Correlated with Improvements
in Metabolic Parameters
Body weight gain, leptin concentration, and EAT and SAT weights were all negatively corre-
lated with Akkermansia, Blautia and OTU 89 (a member of the Ruminococcaceae family; Fig
8); plasma cholesterol levels were also negatively correlated with Akkermansia abundance.
There were positive correlations between SCFA production and the abundance of Akkerman-
sia, Blautia, and OTU 89. OTU 6 and, in most cases, OTU 20 (both members of the Lachnos-
piraceae family) were positively correlated with negative outcomes: body weight gain, fasting
glucose, C-peptide, amylin, plasma cholesterol, leptin, resistin, and the weight of EAT and
SAT. Markers of microbial fermentation of FOPS, including total SCFA, acetate, and cecal
weight were negatively correlated with many host metabolic markers, including body weight
gain, fasting glucose, fasting insulin, index of insulin resistance, C-peptide, adipose tissue
weights, resistin, and leptin. Notably, propionate was significantly correlated with markers of
glucose homeostasis and insulin resistance but not body weight gain and adipose tissue
weights.
Fig 7. Fecal microbiota compositions based on OTU abundance for eachmouse after 0, 1, and 8 weeks of feeding. For FOPSmice, C1, C2, etc.
indicate cage 1, cage 2, etc., while M1, M2, etc. indicate mouse 1, mouse 2, etc.; the color key corresponds to the 25 most abundant OTUs across all time
points.
doi:10.1371/journal.pone.0146144.g007
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Discussion
In this study, we investigated how FOPS affected body weight gain, adipose tissue weights,
markers of metabolic syndrome, and gut microbiota composition in mice fed a HF diet. We
observed disparate metabolic responses to the FOPS diet intervention that were strongly linked
to FOPS-induced changes in gut microbiota composition and function (fermentation to
SCFA). Enhanced cecal fermentation with associated metabolic improvements was evident in
some mice (F-FOPS), while other mice showed normal cecal fermentation and no metabolic
improvements compared with mice in the HF group (N-FOPS).
Significantly lower fasting blood glucose and insulin levels were observed for F-FOPS mice
compared with HF-fed control mice. These improvements in glucose homeostasis in the
F-FOPS mice might be due to enhanced SCFA production from the FOPS fermentation as
butyrate and propionate have been shown to protect against diet-induced obesity as well as
reduce fasting insulin and leptin levels [31]. In particular, F-FOPS mice exhibited substantial
increases in cecal propionate production, which were significantly correlated with reductions
in fasting glucose and insulin levels, the index of insulin resistance, and plasma leptin levels.
Propionate may limit weight gain by partially suppressing food intake [31]; however, in the
present study, we observed no effects on food intake during FOPS feeding. SCFA can also limit
weight gain through increased energy expenditure [32] and improve host metabolism by
Fig 8. Correlations between relative abundance of fecal bacterial OTUs and short and branched chain fatty acids with output variables in HF and
FOPSmice.Only statistically significant correlations are shaded (p<0.05).
doi:10.1371/journal.pone.0146144.g008
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stimulating secretion of the incretin hormone glucagon-like peptide 1 and activating the SCFA
receptor GPR43 [33]. Together, these observations indicate that F-FOPS mice may have experi-
enced improvements in glucose metabolism via enhanced SCFA production.
F-FOPS mice also showed significant reduction in body weight gain compared with HF-fed
mice. However, the mechanism responsible for weight gain reduction appears to be different
from that responsible for improvements in glucose tolerance, as one F-FOPS mouse did not
experience a reduction in fat mass and body weight gain. Interestingly, the three F-FOPS mice
with the greatest improvements in body weight gain, adipose weights, and leptin experienced
dramatic shifts in the composition of their gut microbiota, especially in blooms of the genera
Akkermansia and Blautia. In contrast, these changes were not observed in mice that did not
exhibit these improvements, suggesting that these two bacterial groups may be involved in
mediating these specific benefits. Recent studies have demonstrated an inverse association
between Akkermansia and Blautia and markers of obesity-related metabolic disorders [34–36].
The intake of fructans by obese mice increased the abundance of Akkermansia by ~100 fold
with a concomitant reduction in fat mass gain and adipose tissue inflammation [37]. Akker-
mansiamay affect host metabolism through the enhancement of gut barrier function or pro-
duction of endocannabinoids that control inflammation [38]. In the case of Blautia, diet-
induced obesity strongly reduces the abundance of this genus in mice [39]. Another study sug-
gested that the prevention of obesity and insulin resistance in HF-fed rats with berberine, a yel-
low pigment found in some plant tissues, may be partially mediated by Blautia [40]. Given that
obesity is linked to leptin resistance and that leptin is primarily involved in energy expenditure
[41], the significant decrease in plasma leptin levels in F-FOPS mice (especially in mice 6, 7,
and 8) also suggests enhanced leptin sensitivity in these mice, which might be responsible for
their limited weight gain [41]. Plasma leptin concentration was also negatively correlated with
Akkermansia and Blautia. Together, these findings suggest the importance of Akkermansia
and Blautia in the metabolic improvements related to weight reduction with FOPS.
Our observation of FOPS fermenter and non-fermenter mice was an unexpected finding.
We did not anticipate that inter-individual responsiveness during FOPS feeding would necessi-
tate dividing the mice into two groups, which created a low number of mice and considerable
variation in some of the responses. Despite these limitations, we were still able to observe
remarkable differences in many phenotypes, including body weight gain, adipose tissue
weights, and blood glucose tolerance. These observations clearly support the conclusion that
the metabolic improvements related to glucose homeostasis induced by FOPS are the conse-
quence of colonic fermentation of FOPS and production of SCFA, while the metabolic
improvements related to weight reduction may be linked to the unique gut microbiota compo-
sition, including high proportions of Akkermansia together with Blautia.
It is unclear why mice in the FOPS group responded so differently to the treatment. While
the phenomenon of responders versus non-responders to fiber and prebiotic interventions has
been described in human studies [42, 43], it is less common in mouse studies (although not
unheard of [44]) as genetics and environmental factors are better controlled. Once confirming
that the differences in FOPS responsiveness were not due to cage effects, we hypothesized that
the four mice in the F-FOPS group may have harbored different gut microbiota profiles at
baseline that enabled them to better utilize the FOPS substrate as compared to the N-FOPS
mice. As mentioned, FOPS contains unusual linkages, including (1, 2) and (1, 3)-linkages con-
necting branched chain xylose and arabinose, which may have required the presence of
uncommon carbohydrate-active enzymes to initiate fermentation [45]. Bacteria capable of
expressing such enzymes may allow for the fermentation of FOPS and subsequent changes in
the microbiota by cross feeding. Diversity and PCA plots suggested that the overall community
structures between N-FOPS and F-FOPS at baseline were similar; however, there were subtle
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differences that may be meaningful. For instance, Acetivibrio cellulolyticus, the genus of which
was elevated in the F-FOPS mice, can secrete an α-L-arabinofuranosidase [46], a major struc-
tural component of FOPS. Alternatively, functional differences, not detectable through 16S
rRNA community profiling, may have existed between the FOPS-fed mice that fermented
FOPS and those that did not.
Another possibility is that members within the microbial communities of individual mice
adapted to metabolize the unusual linkages in FOPS. Because such an evolutionary process
would be driven by natural selection after randommutations, it would be, to a large degree, sto-
chastic and dependent on time, thereby causing variation within mice [47]. It is therefore possi-
ble that the study duration may have not been long enough to allow adaptation to occur in all
mice.
Taken together, we observed heterogeneous metabolic adaptation of mice to a FOPS inter-
vention. Our findings provide new evidence for modulating the gut microbiota through dietary
fiber treatment and indicate its contribution to the improvement of host metabolism. Although
we cannot provide a mechanistic explanation for the different responses to FOPS treatment,
our findings provide strong evidence that the metabolic improvements related to glucose
homeostasis induced by FOPS in obese mice are the consequence of colonic fermentation of
FOPS and production of SCFA, while the metabolic improvements related to weight reduction
might be linked to increases of beneficial microbes (e.g., the genus Akkermansia). Our findings
strongly support a causal role of gut bacteria in mediating the health benefits of dietary fiber. In
addition, our findings provide a potential explanation for why the observed metabolic effects of
dietary fiber are often inconsistent in human intervention trials. As humans harbor microbial
communities that are much more individualized than those of experimental mice, they may
therefore differ substantially in their ability to utilize specific fibers and provide benefits.
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